3 edition of Summary of GAO"s findings on the safety and efficacy of the anthrax vaccine found in the catalog.
Summary of GAO"s findings on the safety and efficacy of the anthrax vaccine
United States. General Accounting Office. National Security and International Affairs Division.
by The Office in Washington, D.C. (P.O. Box 37050, Washington, D.C. 20013)
Written in English
|Statement||United States General Accounting Office, National Security and International Affairs Division.|
|The Physical Object|
|Pagination||4,  p.|
It is a dual-action vaccine that simultaneously protects both against the anthrax bacteria and the deadly toxins released by the bacteria. This is important because the anthrax vaccine currently in use only targets the toxins. Comment: If this vaccine is successfully tested in humans, it might help dispel the specter of a future anthrax attack. Interest in the pathogenesis, immunity, and vaccine development for anthrax was heightened by the deliberate contamination of mail with B. anthracis spores soon after the September 11 attacks. At that time, the only US-licensed human vaccine (anthrax vaccine adsorbed, or AVA) was not available because the manufacturer, BioPort Corp., had not Cited by:
Anthrax vaccination is compulsory for certain United States military personnel. • Assurance of anthrax vaccine safety in pregnancy is important for military members. • Infants inadvertently exposed to anthrax vaccine in the 1st trimester are not at higher risk for birth defects. •Cited by: 5. ©— Bioethics Research Library Box Washington DC
Anthrax vaccine is also recommended for unvaccinated people who have been exposed to anthrax in certain situations. These people should get three doses of vaccine (under the skin), with the first dose as soon after exposure as possible, and the second and third doses given 2 and 4 weeks after the first. The War Related Illness and Injury Study Center provides education to Veterans who may have had deployment related exposures. Some Veterans may experience health concerns from exposure to Anthrax Vaccine after a deployment. This page contains information for Veterans on this health condition.
Participatory innovation and representative democracy in Latin America
seven secrets of sales success
Patterning Shakespearean drama
influence of brand repositioning on consumer behaviour
Essays in honor of Hans Tietze: 1880-1954. Directed by Ernst Gombrich, Julius S. Held [and] Otto Kurz.
Colorado River Wild and Scenic River Addition Act of 1990
Assessment of Sexual Dependency
The complete guide to making cheese, butter, and yogurt at home
investigation of the shear characteristics of Palouse clay.
The hidden horse
Beneath this pale cloak
Aspects of the law relating to AIDS
New Contributions to Economic Statistics (Studies in Official Statistics)
And They Called Me Slim
Get this from a library. Summary of GAO's findings on the safety and efficacy of the anthrax vaccine. [United States. General Accounting Office. Anthrax Vaccine: Safety and Efficacy Issues (GAO/T-NSLAD, Oct.
12,). Page 1 GAO/NSIADMR Safety and Efficacy of the Anthrax Vaccine. B NSIADR Summary of GAO's Findings on the Safety and Efficacy of the Anthrax Vaccine Subject: National DefenseFile Size: KB.
Efficacy and Safety of Anthrax Vaccine, GC The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S.
Federal Government. NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Institute of Medicine (US) Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program. An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program.
Washington (DC): National Academies Press (US); Evaluating the efficacy of the Anthrax Vaccine Adsorbed (AVA), particularly against inhalational exposure to anthrax, was a crucial part of this committee's charge.
The charge specifically calls for evaluation of (1) the efficacy of the anthrax vaccine (AVA) in protecting humans from inhalational anthrax, (2) the efficacy of AVA against all known strains of Bacillus anthracis, and Author: Lois M.
Joellenbeck, Lee L. Zwanziger, Jane S. Durch, Brian L. Strom. In An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program, the committee makes an overall assessment of the CDD research plan and reviews the specific studies proposed by CDC in the three areas of efficacy, safety and acceptability.
The committee also notes additional research needs that became evident following the. J ) and Medical Readiness: Safety and Efficacy of the Anthrax Vaccine (GAO/T-NSIAD, Ap ).
Page 2 GAO/T-NSIAD Summary No studies have been done to determine the optimum number of doses of the anthrax vaccine. Although annual boosters are given, the need for a.
Pursuant to a congressional request, GAO discussed the results of its ongoing examination of the safety and efficacy of the anthrax vaccine, focusing on the: (1) need for a six-shot regimen and annual booster shots; (2) long- and short-term safety of the vaccine; (3) efficacy of the vaccine; (4) extent to which problems the Food and Drug Administration (FDA) found in the vaccine.
The safety and efficacy of administering the anthrax vaccine during the same visit as other licensed vaccines has not been evaluated. If an anthrax vaccine is to be given during the same visit as another injectable vaccine, the vaccines should be administered at different injection sites, if feasible.
There is a vaccine that can help prevent anthrax, a serious infection caused by the bacterium Bacillus r, this vaccine is not typically available for the general public.
It is only recommended for people who are at an increased risk of coming into contact with or have already been exposed to B. anthracis. Talk with your healthcare professional if you have. The Anthrax Vaccine: Is It Safe. Does It Work. [Institute of Medicine, Medical Follow-up Agency, Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Strom, Brian L., Durch, Jane S., Zwanziger, Lee L., Joellenbeck, Lois M.] on *FREE* shipping on qualifying offers.
The Anthrax Vaccine: Is It Safe. Does It Work?Format: Paperback. British anthrax vaccines. British biochemist Harry Smith (–), working for the UK bio-weapons program at Porton Down, discovered the three anthrax toxins in This discovery was the basis of the next generation of antigenic anthrax vaccines and for modern antitoxins to anthrax.
The widely used British anthrax vaccine—sometimes called Anthrax Vaccine. The vaccine hoax is slowing being exposed, and this book is a MUST READ if you have received the mandatory Anthrax vaccine from the United States Military. Those huge, red, painful whelps from the injection are ominous, and although the military will tell that these reactions are normal, the side effects are NOT/5(63).
The Anthrax Vaccine by Committee to Assess the Safety and Efficacy of the Anthrax Vaccine,available at Book Depository with free delivery worldwide. Maine doctor Meryl Nass, MD, has studied anthrax for the past 13 years, and testified before Congress two years ago on the vaccine's safety.
"There are no data at all on long-term reactions," Nass Author: Salynn Boyles. A human vaccine was licensed in Vaccination against anthrax has been confined to people at risk, such as wool sorters and some veterinarians.
However, the rising prospects of B. anthracis being used as a weapon have led to routine administration of the anthrax vaccine to members of the armed forces. Anthrax: the green book, chapter 13 This revision provides updated advice on the need for and timing of booster doses for anthrax vaccine.
The Institute for Vaccine Safety has not conducted an independent assessment of the safety or effectiveness of anthrax vaccine, but is providing links for interested readers. References. King JC Jr, et al. Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.
King JC Jr, Gao Y, Quinn CP, et al. Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.
Vaccine. ;33(21) Biron B, Beck K, Dyer D, et al. Efficacy of ETI monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for.
The Anthrax Vaccine: Source One of the most difficult problems in dealing with anthrax vaccine safety is obtaining specific information on the anthrax vaccine and how ii was deter- mined to be safe.
Most military vac- cines in the U.S. are )rn ole-source by: 6. Anthrax vaccine adsorbed (AVA) is the only FDA-licensed human anthrax vaccine in the United States. It is produced under the trade name BioThrax by the Emergent BioDefense Corporation (formerly known as BioPort Corporation) in Lansing, parent company of Emergent BioDefense is Emergent BioSolutions of Rockville, is sometimes called MDPH-PA Target disease: Anthrax.
Daniel Bettis, operation manager, holds a vial with an individual dose of an Anthrax vaccine at VaxGen in South San Francisco, Calif., Friday Ma Anthrax is a zoonotic disease, primarily of ruminants, that is caused by Bacillus anthracis.
The three most common forms of anthrax are cutaneous, inhalational, and gastrointestinal.